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Abstract
The method of instrumental variable (referred to as Mendelian randomization when the instrument is a genetic variant) has
been initially developed to infer on a causal effect of a risk factor on some outcome of interest in a linear model. Adapting
this method to nonlinear models, however, is known to be problematic. In this paper, we consider the simple case when the
genetic instrument, the risk factor, and the outcome are all binary. We compare via simulations the usual two-stages
estimate of a causal odds-ratio and its adjusted version with a recently proposed estimate in the context of a clinical trial
with noncompliance. In contrast to the former two, we confirm that the latter is (under some conditions) a valid estimate of
a causal odds-ratio defined in the subpopulation of compliers, and we propose its use in the context of Mendelian
randomization. By analogy with a clinical trial with noncompliance, compliers are those individuals for whom the presence/
absence of the risk factor X is determined by the presence/absence of the genetic variant Z (i.e., for whom we would
observe X= Z whatever the alleles randomly received at conception). We also recall and illustrate the huge variability of
instrumental variable estimates when the instrument is weak (i.e., with a low percentage of compliers, as is typically the case
with genetic instruments for which this proportion is frequently smaller than 10%) where the inter-quartile range of our
simulated estimates was up to 18 times higher compared to a conventional (e.g., intention-to-treat) approach. We thus
conclude that the need to find stronger instruments is probably as important as the need to develop a methodology
allowing to consistently estimate a causal odds-ratio.
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Introduction
The method of instrumental variable has been introduced
nearly one century ago in econometrics [1]. It can be used for
estimating a causal effect of a risk factor (predictor, phenotype) X
on some outcome Y in observational studies in epidemiology,
where unknown and unmeasured confounding effects U are often
unavoidable. It can also be used to correct for noncompliance in
clinical trials [3]. The method uses an ‘‘instrument’’ Z which needs
to be (i) correlated with X; (ii) independent from U; and (iii)
conditionally independent from Y given X and U [3,4], as
illustrated in Figure 1. In general, conditions (ii) and (iii) are the
problematic ones, since they cannot be verified from the data and
should be justified based on subject-matter knowledge. Examples
of instruments are the random group assignment in a clinical trial,
or a genetic variant associated to the risk factor of interest in an
observational study. In the latter case, the method of instrumental
variable is often referred to as Mendelian randomization [5].
The method of instrumental variable has been devised to
provide a consistent estimate of a causal effect of X on Y when the
relationship is linear, and thus typically applies when the outcome
is continuous. It also applies to a binary outcome if the causal
effect can be expressed as a risk difference. For a binary outcome,
however, a relationship is usually described via an odds-ratio, not a
risk difference. Some adaptation of the method of instrumental
variable have been proposed to estimate a causal odds-ratio, such
as the downloadable qvf function [6] implemented in Stata (Stata
Corp, College Station, Texas), or its adjusted version proposed by
Nagelkerke et al. [7] and by Palmer et al. [8]. However, it is not
yet totally clear in which situations and to which extent these
adaptations are valid. In their review, Bochud and Rousson [9]
identified 37 observational studies which have used the method of
Mendelian randomization between 2004 and 2010, where 23 (i.e.
about 60%) considered a binary outcome. They concluded their
review stating that ‘‘Considering the clear interest for epidemiol-
ogists to apply this concept for dichotomous outcomes such as
diseases, it would be important, and even urgent, to clarify the
issues of the validity of the instrumental variable approach in this
context’’. Some recent clarification in this regard have been made
in Didelez, Meng and Sheehan [10], in Vansteelandt et al. [11]
and in Palmer et al. [12].
One conclusion of Palmer et al. [12] was that the above
adaptations of the method of instrumental variable should not be
used for estimating a causal odds-ratio when Z, X and Y are all
binary. However, another estimate of a causal odds-ratio, which
also uses an instrumental variable, has recently been proposed by
Lui and Chang [13] in the context of a clinical trial with
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noncompliance. In the present paper, we compare via simulations
the usual qvf method and its adjusted version with the method of
Lui and Chang [13], confirming that the latter method provides
an approximately unbiased estimate of a causal odds-ratio defined
in the subpopulation of ‘‘compliers’’, while illustrating the bias of
the former two methods. Thus, we suggest to use the latter method
rather than the former two methods in the context of a Mendelian
randomization when the genetic instrument Z, the risk factor X
and the outcome Y are all binary, and we illustrate its use with an
applied example.
The paper is organized as follows. In the Methods section, we
recall how the method of instrumental variable can be used to
estimate a causal risk difference, and we present the qvf method
and its adjusted version for estimating a causal odds-ratio, as well
as the method of Lui and Chang [13] which is derived in some
details. Our simulations are presented in the Results section, where
we also give an example and provide further comparison with
other possible estimates of a causal odds-ratio, in particular the
logistic structural mean model estimate proposed by Vansteelandt
and Goetghebeur [14]. Some concluding remarks take place in the
Discussion section.
Methods
Estimating a Causal Risk Difference
In this subsection, we recall how it is possible to estimate a
causal risk difference using the method of instrumental variable.
Let X be a risk factor, Y an outcome, and Z an instrument
satisfying the conditions (i), (ii) and (iii) outlined in the Introduc-
tion. In this paper, we consider the case where X, Y and Z are all
binary (with possible values 0 and 1). Although we shall later
switch to the problem of Mendelian randomization, we first
consider the case of a randomized clinical trial comparing two
treatments with respect to a binary outcome (for which the method
of Lui and Chang [13] has been originally derived). There Z
denotes the random group assignment, while X denotes the
treatment which is actually taken by the participants. The
variables X and Z may differ for some individuals if noncompli-
ance occurs. In what follows, we consider a sample of n individuals,
where nijk denotes the number of individuals with Z~i, X~j and
Y~k for i,j,k~0,1. We thus have the situation presented in
Table 1.
We first review in this subsection how it is possible to estimate
the causal effect of the treatment X on the outcome Y defined via a
risk difference. A naive estimate, in what follows the ‘‘as-treated’’
estimate, would simply compare the empirical proportions of
Y~1 in the groups X~1 and X~0 as follows:
bdAT~ n011zn111
n010zn110zn011zn111
{
n001zn101
n000zn100zn001zn101
:
On the other hand, another well-known estimate, the ‘‘inten-
tion-to-treat’’ estimate, compares the empirical proportions of
Y~1 in the groups Z~1 and Z~0 as follows:
bdITT~ n101zn111
n100zn110zn101zn111
{
n001zn011
n000zn010zn001zn011
:
Note that bdAT and bdITT can also be defined as the estimated
slopes in a linear regression of Y on X, respectively of Y on Z. On
the other hand, the ‘‘instrumental variable’’ estimate is a ratio of
two slope estimates, from a linear regression of Y on Z and from a
linear regression of X on Z. The numerator is therefore the
intention-to-treat estimate, while the denominator compares the
empirical proportion of X~1 in the groups Z~1 and Z~0. The
instrumental variable estimate is thus given by
bdIV~ bdITTn110zn111
n100zn110zn101zn111
{
n010zn011
n000zn010zn001zn011
:
To see which population parameter is hence estimated, we shall
distinguish among four categories of individuals, as done in
Angrist, Imbens and Rubin [15]. The ‘‘compliers’’ are those
individuals for whom a random assignment Z~0 would imply
X~0 and a random assignment Z~1 would imply X~1. Non-
compliers include the ‘‘always-takers’’ (for whom X~1 whatever
the value of Z), the ‘‘never-takers’’ (for whom X~0 whatever the
value of Z) and the ‘‘defiers’’ (for whom Z~0 would imply X~1
and Z~1 would imply X~0). Given the data of a clinical trial,
however, it is not possible to tell which of these four categories an
individual belongs to, since one cannot infer from the data what
he/she would have done if he/she would have been assigned to
the other group. In the absence of noncompliance, the three above
estimates are identical. When noncompliance occurs, however,
these estimates usually differ from each other and converge (as
sample size increases) towards different population parameters. Let
vC , vA, vN and vD be the proportion of compliers, always-takers,
never-takers and defiers in the target population (such that
vCzvAzvNzvD~1). Let p0C , p0A, p0N and p0D be the
Figure 1. Directed acyclic graph (DAG) representing condition-
al independencies (by the absence of arrows) between the
genetic instrument Z, the risk factor X, the outcome Y and the
confounders U.
doi:10.1371/journal.pone.0035951.g001
Table 1. Allocation of the n individuals of a sample according
to Z, X and Y.
Z~0 Z~1
X~0 X~1 X~0 X~1
Y~0 n000 n010 n100 n110
Y~1 n001 n011 n101 n111
doi:10.1371/journal.pone.0035951.t001
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proportions of Y~1 for compliers, always-takers, never-takers and
defiers in the group Z~0, and similarly let p1C , p1A, p1N and p1D
be the proportions of Y~1 in the group Z~1. Finally, let r be
the proportion of individuals with Z~1 (e.g., r~0:5 in a clinical
trial comparing two groups of equal size). Using condition (ii) in
the Introduction section, one can easily derive the following results
(in a similar spirit as was done e.g. in Greenland [2]):
NThe estimate bdAT converges towards population parameter
dAT~
rvCp1CzrvAp1Az(1{r)vAp0Az(1{r)vDp0D
rvCzvAz(1{r)vD
{
(1{r)vCp0Cz(1{r)vNp0NzrvNp1NzrvDp1D
(1{r)vCzvNzrvD
:
We here compare a group formed of compliers, always-takers and
defiers with a group formed of compliers, never-takers and defiers.
Since always-takers may have quite different characteristics than
never-takers, it is not obvious to provide this parameter with any
useful interpretation.
NThe estimate bdITT converges towards population parameter
dITT~vC(p1C{p0C)zvA(p1A{p0A)z
vN (p1N{p0N )zvD(p1D{p0D):
This parameter can be interpreted as the average causal effect of
Z on Y which can be interesting to assess the effect of a public
health policy, noncompliance in the sample mimicking the fact
that not every person in the target population will strictly follow
the official recommendations, for example.
NThe estimate bdIV converges towards population parameter
dIV~
vC(p1C{p0C)zvA(p1A{p0A)zvN (p1N{p0N )zvD(p1D{p0D)
vC{vD
:
To calculate the denominator, note that the empirical
proportion of X~1 in the group Z~1 is an estimate of
vCzvA, while the empirical proportion of X~1 in the group
Z~0 is an estimate of vDzvA, the difference being hence
vC{vD.
To get a causal interpretation for the latter estimate, note first
that condition (iii) in the Introduction section implies p1A~p0A
and p1N~p0N (the outcome Y for always-takers and never-takers
is not influenced in any respect by the value of Z), whereas
condition (i) ensures that its denominator does not converge
towards zero. One may then make the additional assumption that
(A1) there are no defiers ( v D~0):
In the terminology of Angrist, Imbens and Rubin [15], (A1) is
the ‘‘monotonicity assumption’’. Using this additional assumption,
the estimate bdIV converges thus towards population parameter
d~p1C{p0C ,
which can be interpreted as the average causal effect of X on Y in
the subpopulation of compliers [15].
In the context of a Mendelian randomization, the instrument Z
will be a genetic variant associated to a risk factor X, and the
causal parameter d which is estimated using the method of
instrumental variable can be interpreted as the risk difference that
one would get if one could intervene and change the risk factor X
from 0 to 1 in the subpopulation of compliers. By analogy with a
clinical trial with noncompliance, a complier is an individual for
whom the presence/absence of the risk factor X is determined by
the presence/absence of the genetic variant Z, i.e. for whom we
would observe X~Z whatever the alleles randomly received at
conception. This definition of a complier actually refers to a causal
link between Z and X and we shall also make this assumption in
what follows.
Estimating a Causal Odds-ratio
It is however more common to define the effect of a binary risk
factor X on a binary outcome Y as an odds-ratio rather than a risk
difference. Restricting our attention to the subpopulation of
compliers, the parameter of interest would thus become
y~
p1C(1{p0C)
p0C(1{p1C)
:
Again, in the context of a Mendelian randomization approach,
this causal parameter y can be interpreted as the odds-ratio which
one would get if one could intervene and change X from 0 to 1 in
the subpopulation of compliers. The naive, or as-treated, estimate
of y could be expressed as the odds of having Y~1 in the group
X~1 divided by the odds of having Y~1 in the group X~0,
yielding
byAT~ (n011zn111)(n000zn100)(n001zn101)(n010zn110) ,
while the intention-to-treat could be expressed as the odds of
having Y~1 in the group Z~1 divided by the odds of having
Y~1 in the group Z~0, yielding
byITT~ (n101zn111)(n000zn010)(n001zn011)(n100zn110) :
In general, both estimates are not consistent for y if
noncompliance occurs. On the other hand, estimating the
parameter y with the classical method of instrumental variable
is not obvious. In the qvf function of Stata, one estimates log (y) as
the ratio of two slope estimates, from a logistic regression of Y on Z
and from a linear regression of X on Z, yielding
Mendelian Randomization with All Binary Data
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byIV~ exp
log byITT
 
n110zn111
n100zn110zn101zn111
{
n010zn011
n000zn010zn001zn011
0
@
1
A:
Alternatively, log (byIV ) is the estimated slope in a ‘‘second
stage’’ logistic regression of Y on , where represents the fitted
values calculated from a ‘‘first stage’’ linear regression of X on Z,
that is ~(n110zn111)=(n100zn110zn101zn111) for those individ-
uals with Z~1 and ~(n010zn011)=(n000zn010zn001zn011) for
those individuals with Z~0. Thus, the byIV estimate is sometimes
referred to as a two-stages estimate. Nagelkerke et al. [7], as well as
Palmer et al. [8], proposed to improve this estimate by considering
in the second stage a logistic regression with Y as the response and
with two explanatory variables: and R~X{ (or equivalently, X
and R). The estimated slope associated to (respectively to X) in this
second stage regression is another estimate of log (y)9, yielding by
exponentiation the adjusted instrumental variable estimate, in what
follows byADJ . In the econometrics literature, this estimate is known
as the ‘‘control function estimate’’. Note that Palmer et al. [8]
considered this estimate with a continuous X in the context of
Mendelian randomization. Nagelkerke et al. [7] used this estimatebyADJ with a binary X in the context of a clinical trial with
noncompliance, and interpreted it as an estimate of a causal odds-
ratio in the subpopulation of the compliers, i.e. as an estimate of y.
There is however another method to estimate this causal odds-
ratio y, as recently proposed by Lui and Chang [13] and as
explained in what follows. While it is not possible to know for each
person who is a complier, an always-taker or a never-taker, note
that the n00~n000zn001 individuals in the first column from
Table 1 include compliers and never-takers, the n01~n010zn011
individuals in the second column are always-takers, the
n10~n100zn101 individuals in the third column are never-takers,
and the n11~n110zn111 individuals in the last column include
compliers and always-takers (recall that we assume no defiers).
Since Z is an instrumental variable (which is independent from all
possible confounding variables), we expect the same proportions of
compliers, always-takers and never-takers in both groups (Z~0
and Z~1). In the group Z~0, it is hence possible to estimate vA
without bias using bvA~n01=(n00zn01). In the group Z~1, it is
possible to estimate vN without bias using bvN~n10=(n10zn11).
An unbiased estimate of vC~1{vA{vN is then obtained asbvC~1{bvA{bvNo. Let p1CA be the proportion of Y~1 expected
in the last column (Z~X~1) which is equal to
p1CA~
vCp1CzvAp1A
vCzvA
:
This implies
p1C~
(vCzvA)p1CA{vAp1A
vC
:
Similarly, let p0CN be the proportion of Y~1 expected in the
first column (Z~X~0) which is equal to
p0CN~
vCp0CzvNp0N
vCzvN
:
This implies
p0C~
(vCzvN )p0CN{vNp0N
vC
:
It is then possible to estimate without bias p1CA and p0CN using
the data from the last and the first column, respectively yieldingbp1CA~n111=n11 and bp0CN~n001=n00. It is also possible to estimate
without bias p1A and p0N using the data from the second and the
third columns, respectively yielding bp1A~n011=n01 andbp0N~n101=n10. It follows that consistent estimates of p1C and
p0C are given by
bp1C~ (bvCzbvA)bp1CA{bvAbp1AbvC
and by
bp0C~ (bvCzbvN )bp0CN{bvNbp0NbvC ,
respectively. A consistent estimate of y is then given by
byLC~bp1C(1{bp0C)bp0C(1{bp1C) ,
which can also be expressed as
byLC
~
(n00zn01)n111{(n10zn11)n011f g (n10zn11)n000{(n00zn01)n100f g
(n00zn01)n110{(n10zn11)n010f g (n10zn11)n001{(n00zn01)n101f g :
This estimate has been proposed by Lui and Chang [13],
without providing all the details about the intermediate estimatesbvC , bvA, bvN , bp1A and bp0N given here, which also provide useful
information as illustrated in our example below. In the special case
where noncompliance occurs only in one group, this estimate
coincides with the estimate proposed by Sommer and Zeger [16].
In a more general context involving a multinomial outcome, Baker
[17] showed that the estimates bp1C and bp0C above are the
maximum likelihood estimates of p1C and p0C if they are lying
between 0 and 1.
Results
Simulations
In this subsection, we present the results of simulations which
were run to assess the performance of byIV , byADJ and byLC as
estimates of the causal parameter y above. Estimates byAT andbyITT were also included in the comparison. In our simulation
design, we considered all possible combinations of the following
five factors:
1. Proportion of compliers (low, middle, high)
? The proportion of compliers was set to vC~0:1,0:5 or 0.9,
while we took equal proportions of always-takers and never-takers,
i.e. vA~vN~(1{vC)=2.
Mendelian Randomization with All Binary Data
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2. Baseline prevalence (small, medium)
? The proportion of Y~1 for compliers in the group Z~0 was
set to p0C~0:1 or 0.5.
3. Odds-ratio (no effect, medium effect, large effect)
? The true odds ratio was set to y~1,3 or 9. Thus, we took the
proportion of Y~1 for compliers in the group Z~1 as
p1C~0:1,0:25 or 0.5 when p0C~0:1, and as p1C~0:5,0:75 or
0.9 when p0C~0:5.
4. Confounding effect (small confounding, high confounding)
? The proportions of Y~1 for always-takers was chosen such that
the odds was 1.5 or 3 times higher than for compliers, while the
proportion of Y~1 for never-takers was set such that the odds was
1.5 times higher than for compliers. Thus, we took p0N and p1A
such that p0N=(1{p0N )~1:5:p0C=(1{p0C) and p1A=(1{p1A)~
1:5:p1C=(1{p1C), respectively p1A=(1{p1A)~3:p1C=(1{p1C).
This yielded p0N~1=7 when p0C~0:1, p0N~0:6 when
p0C~0:5, p1A~1=7 or 0.25 when p1C~0:1, p1A~1=3 or 0.5
when p1C~0:25, p1A~0:6 or 0.75 when p1C~0:5, p1A~9=11 or
0.9 when p1C~0:75 and p1A~27=29 or 27/28 when p1C~0:9.
5. Total sample size (small, medium)
? Two sample sizes were used, namely n~200 and n~2000,
where n denotes the total sample size over both groups Z~0 and
Z~1, the proportion of individuals with Z~1 being set to r~0:5
throughout.
For each of these 72 possible combinations of levels, we
repeated 2000 simulations. In each replication, the five estimates
have been calculated. All simulations were performed using R
(version 2.11.1) [18].
We encountered the following technical problems when
calculating byLC . When the true proportion of compliers was low
(vC~0:1), the estimated proportion of compliers bvC was smaller
than zero in 7.7% of the replications when n~200 (the problem
never happened when n~2000). In those cases, we set byLC~1
since no effect can be estimated without compliers. Another
technical problem was that bp0C and bp1C were sometimes outside
the range of possible values (0.1). In those cases, values smaller
than 0 were set to 0 and values larger than 1 were set to 1, yielding
estimated odds-ratios of zero or plus infinity. This situation arose
in about 60% of the replications when vC~0:19 and n~200.
This problem remained in about 15% of the replications when
increasing the sample size to n~2000, but disappeared when
increasing the proportion of compliers to vC~0:5.
In each replication, the F-statistic from the first stage regression
in the instrumental variable approach (the linear regression of X
on Z) was also calculated. According to Stock, Wright and Yogo
[19], a value of Fv10 suggests a weak instrument, for which the
validity of the inference is not guaranteed. For vC~0:1 and
n~200, this happened in 95% of the replications. Since the
method of instrumental variable is not valid in that setting, we
shall not present those results in what follows, leaving us with 60
combinations of levels (this also removed most of the technical
problems mentioned above). Note that we still had a value of
Fv10 in about 10% of the replications for vC~0:1 and n~2000,
but these replications were kept to avoid a possible selection bias,
as explained in Burgess and Thompson [20]. Results are shown in
Table 2. To get a robust estimate of the bias and to cope with the
estimated odds-ratios of zero or infinity, we report in this table, for
each combination of levels and for each estimate, the median of
2000 estimates divided by the true odds-ratio (i.e. median (by)=y).
This ratio should be approximately 1 for an unbiased method. In
addition, Spearman correlations among the three estimates of
main interest byIV , byADJ and byLC calculated over the 2000
estimates are also reported.
As is well known, the intention-to-treat estimate consistently
underestimated the true odds-ratio (even in some situations with
90% of compliers), whereas the as-treated estimate might be
biased in both directions, also in cases with no effect. Among the
three estimates of main interest, we first notice that byIV and byADJ
did not differ much, byADJ being usually slightly higher than byIV
and the correlation between the two estimates being most of the
time above 0.98. Both methods were often biased, sometimes
downwards and sometimes upwards. The bias was usually larger
with higher odds ratios, larger confounding effects and a smaller
proportion of compliers. Importantly, the situation did not
improve with a larger sample size. By contrast, the bias of thebyLC estimate was pretty small, the ratio above being comprised
between 0.95 and 1.19 in all considered situations, and the bias
would still be smaller by further increasing the sample size.
Besides the bias, we also investigated the variability of the
estimates. Figure 2 shows how the inter-quartile range (IQR)
calculated from the 2000 estimates of the log odds-ratios depends
on the proportion of compliers in the case n~2000 and for
different combinations of levels. For this, additional simulations
have been carried out with vC~0:2,0:3 and 0.4 (in addition to
vC~0:1,0:5 and 0.9). The IQR for the different estimates were
divided by the IQR achieved by byAT , which is the reference
method in this figure (would be represented by a horizontal line
drawn at the value 1). The three instrumental variable approaches
showed a much higher variability than the as-treated and the
intention-to-treat estimates, especially when the proportion of
compliers was small. For vC~0:1, the IQR of byIV and byADJ were
up to 10 times higher than the IQR of byAT , whereas the IQR ofbyLC was up to 18 times higher in the case of a small prevalence.
For a medium baseline prevalence, the IQR of the three estimatesbyIV , byADJ and byLC became more comparable with each other.
Increasing the level of the odds-ratio or of the confounding effect
did not change the results much. The complete results on the IQR
for the different estimates are available from the first author upon
request.
Figure 3 illustrates both the bias and the variability of the
different methods with the boxplots of the 2000 estimates of the log
odds-ratios calculated under various settings in the case n~2000
and vC~0:5. One can retrieve our conclusions above. We also
performed simulations using other combinations of levels, e.g.,
where the proportion of Y~1 was taken higher for compliers than
for always-takers and never-takers, and similar conclusions could
be drawn (apart from the direction of the bias for byAT , byIV andbyADJ ).
Example
In this subsection, we illustrate how the method of Lui and
Chang [13] can be used in a context of Mendelian randomization
using a partly fictitious example. We consider the effect of alcohol
consumption X on hypertension Y. In what follows, X~1 refers to
individuals who drink alcohol, and Y~1 refers to people with
hypertension. It is well known that the aldehyde dehydrogenase 2
(ALDH2) genotype is strongly associated with alcohol consumption
since it encodes an enzyme involved in alcohol metabolism and
this relationship might reasonably assumed to be causal [21]. The
presence of a protective allele in one of the markers of the ALDH2
gene has been used as an instrument Z, since it is supposed to be
responsible for a decrease in alcohol consumption. In what follows,
Z~0 refers to individuals with this protective allele. In this
context, a complier is an individual whose phenotype would be
determined by his/her genotype (i.e. no alcohol consumption if the
protective allele were present (Z~X~0), and consumption if the
protective allele were absent (Z~X~1)). In contrast, an always-
Mendelian Randomization with All Binary Data
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Table 2. Summary results of 2000 simulations under various situations for each of the five methods.
design bias (median (by)=y) Spearman correlations
y p0C p1C p0N p1A vzC n byAT byITT byIV byADJ byLC byIV{byADJ byIV{byLC byADJ{byLC
1 0.10 0.10 0.14 0.14 0.50 200 1.006 1.000 1.000 0.999 1.000 1.00 0.97 0.97
3 0.10 0.25 0.14 0.33 0.50 200 1.003 0.531 0.849 0.896 1.033 1.00 0.91 0.91
9 0.10 0.50 0.14 0.60 0.50 200 1.007 0.280 0.707 0.851 1.071 0.99 0.85 0.86
1 0.10 0.10 0.14 0.25 0.50 200 1.533 0.995 0.990 1.003 0.997 1.00 0.96 0.96
3 0.10 0.25 0.14 0.50 0.50 200 1.444 0.494 0.725 0.776 0.996 0.99 0.91 0.91
9 0.10 0.50 0.14 0.75 0.50 200 1.369 0.264 0.639 0.723 1.078 0.99 0.85 0.86
1 0.50 0.50 0.60 0.60 0.50 200 1.008 1.001 1.002 1.004 1.002 1.00 1.00 1.00
3 0.50 0.75 0.60 0.82 0.50 200 0.993 0.585 1.043 1.067 1.020 1.00 0.99 0.99
9 0.50 0.90 0.60 0.93 0.50 200 0.991 0.319 0.940 1.257 1.027 0.98 0.88 0.89
1 0.50 0.50 0.60 0.75 0.50 200 1.364 0.987 0.972 0.966 0.972 1.00 1.00 1.00
3 0.50 0.75 0.60 0.90 0.50 200 1.281 0.602 1.091 1.136 1.029 1.00 0.99 0.99
9 0.50 0.90 0.60 0.96 0.50 200 1.278 0.334 0.999 1.480 1.076 0.97 0.89 0.92
1 0.10 0.10 0.14 0.14 0.90 200 0.990 0.961 0.956 0.955 0.952 0.99 1.00 0.99
3 0.10 0.25 0.14 0.33 0.90 200 1.019 0.870 0.971 0.988 1.025 0.98 0.97 0.97
9 0.10 0.50 0.14 0.60 0.90 200 1.011 0.738 0.908 0.957 1.023 0.91 0.95 0.90
1 0.10 0.10 0.14 0.25 0.90 200 1.137 1.005 1.006 1.009 1.006 0.99 1.00 0.98
3 0.10 0.25 0.14 0.50 0.90 200 1.103 0.824 0.912 0.946 1.007 0.96 0.97 0.95
9 0.10 0.50 0.14 0.75 0.90 200 1.083 0.708 0.879 0.876 1.019 0.82 0.95 0.82
1 0.50 0.50 0.60 0.60 0.90 200 1.003 1.001 1.001 1.001 1.001 0.99 1.00 0.99
3 0.50 0.75 0.60 0.82 0.90 200 1.017 0.903 1.015 1.009 1.009 0.98 1.00 0.97
9 0.50 0.90 0.60 0.93 0.90 200 1.014 0.790 0.978 1.041 1.012 0.96 0.97 0.95
1 0.50 0.50 0.60 0.75 0.90 200 1.069 0.999 0.999 0.996 0.999 0.98 1.00 0.98
3 0.50 0.75 0.60 0.90 0.90 200 1.043 0.912 1.014 1.011 1.005 0.98 1.00 0.98
9 0.50 0.90 0.60 0.96 0.90 200 1.067 0.804 1.003 1.063 1.032 0.95 0.97 0.94
1 0.10 0.10 0.14 0.14 0.10 2000 0.998 1.000 1.002 1.002 1.000 1.00 0.94 0.94
3 0.10 0.25 0.14 0.33 0.10 2000 0.992 0.364 0.792 0.825 1.123 1.00 0.88 0.88
9 0.10 0.50 0.14 0.60 0.10 2000 0.992 0.132 0.603 0.712 1.086 1.00 0.82 0.82
1 0.10 0.10 0.14 0.25 0.10 2000 1.908 1.001 1.007 1.010 1.000 1.00 0.93 0.93
3 0.10 0.25 0.14 0.50 0.10 2000 1.890 0.358 0.671 0.678 1.000 1.00 0.90 0.90
9 0.10 0.50 0.14 0.75 0.10 2000 1.821 0.131 0.572 0.570 1.185 1.00 0.79 0.79
1 0.50 0.50 0.60 0.60 0.10 2000 0.998 0.996 0.958 0.958 0.958 1.00 1.00 1.00
3 0.50 0.75 0.60 0.82 0.10 2000 0.996 0.375 1.069 1.124 1.048 1.00 0.98 0.98
9 0.50 0.90 0.60 0.93 0.10 2000 0.999 0.139 1.019 1.531 1.146 1.00 0.83 0.84
1 0.50 0.50 0.60 0.75 0.10 2000 1.834 1.000 1.002 0.998 1.002 1.00 1.00 1.00
3 0.50 0.75 0.60 0.90 0.10 2000 1.787 0.381 1.249 1.418 1.084 1.00 0.98 0.98
9 0.50 0.90 0.60 0.96 0.10 2000 1.747 0.140 1.099 2.225 1.122 1.00 0.84 0.84
1 0.10 0.10 0.14 0.14 0.50 2000 1.004 1.002 1.005 1.005 1.006 1.00 1.00 1.00
3 0.10 0.25 0.14 0.33 0.50 2000 0.998 0.530 0.843 0.877 1.003 1.00 0.94 0.94
9 0.10 0.50 0.14 0.60 0.50 2000 0.986 0.280 0.705 0.846 1.015 0.99 0.89 0.90
1 0.10 0.10 0.14 0.25 0.50 2000 1.534 1.001 1.003 1.006 1.004 1.00 1.00 1.00
3 0.10 0.25 0.14 0.50 0.50 2000 1.444 0.501 0.754 0.792 1.012 1.00 0.93 0.94
9 0.10 0.50 0.14 0.75 0.50 2000 1.343 0.266 0.636 0.721 1.008 0.99 0.88 0.89
1 0.50 0.50 0.60 0.60 0.50 2000 1.003 1.003 1.007 1.007 1.006 1.00 1.00 1.00
3 0.50 0.75 0.60 0.82 0.50 2000 0.987 0.587 1.035 1.065 0.996 1.00 0.99 0.99
9 0.50 0.90 0.60 0.93 0.50 2000 0.986 0.321 0.928 1.222 1.012 0.98 0.90 0.91
1 0.50 0.50 0.60 0.75 0.50 2000 1.365 1.001 1.001 0.999 1.001 1.00 1.00 1.00
3 0.50 0.75 0.60 0.90 0.50 2000 1.289 0.599 1.078 1.129 0.996 1.00 0.99 0.99
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Table 2. Cont.
design bias (median (by)=y) Spearman correlations
y p0C p1C p0N p1A vzC n byAT byITT byIV byADJ byLC byIV{byADJ byIV{byLC byADJ{byLC
9 0.50 0.90 0.60 0.96 0.50 2000 1.251 0.329 0.979 1.400 1.004 0.98 0.90 0.93
1 0.10 0.10 0.14 0.14 0.90 2000 1.001 1.001 1.001 1.001 1.001 1.00 1.00 1.00
3 0.10 0.25 0.14 0.33 0.90 2000 0.995 0.861 0.955 0.971 0.999 1.00 0.98 0.98
9 0.10 0.50 0.14 0.60 0.90 2000 1.000 0.728 0.897 0.970 1.007 0.99 0.96 0.97
1 0.10 0.10 0.14 0.25 0.90 2000 1.115 1.002 1.002 1.005 1.003 1.00 1.00 1.00
3 0.10 0.25 0.14 0.50 0.90 2000 1.086 0.832 0.922 0.950 1.003 0.99 0.98 0.98
9 0.10 0.50 0.14 0.75 0.90 2000 1.056 0.699 0.858 0.932 1.005 0.98 0.96 0.97
1 0.50 0.50 0.60 0.60 0.90 2000 1.004 1.001 1.001 1.001 1.001 1.00 1.00 1.00
3 0.50 0.75 0.60 0.82 0.90 2000 0.998 0.899 1.004 1.011 1.000 1.00 1.00 1.00
9 0.50 0.90 0.60 0.93 0.90 2000 0.998 0.783 0.973 1.041 1.004 0.99 0.97 0.98
1 0.50 0.50 0.60 0.75 0.90 2000 1.060 0.996 0.995 0.995 0.995 1.00 1.00 1.00
3 0.50 0.75 0.60 0.90 0.90 2000 1.043 0.905 1.009 1.017 0.999 1.00 1.00 1.00
9 0.50 0.90 0.60 0.96 0.90 2000 1.041 0.798 0.991 1.065 1.008 0.99 0.97 0.99
doi:10.1371/journal.pone.0035951.t002
Figure 2. IQR of the log odds-ratios estimated from 2000 simulations under various situations for each of the five methods in
function of the proportion of compliers vC . IQR of estimates byITT (dashed-dotted line), byIV (dashed line), byADJ (dotted line) and byLC (solid
line) have been divided by the IQR of estimate byAT . The sample size is n~2000.
doi:10.1371/journal.pone.0035951.g002
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taker is an individual who would drink alcohol, and a never-taker
is an individual who would not drink alcohol, whatever his/her
genotype. Recall also that we assume no defiers, i.e. there is no one
who would drink alcohol if and only if the protective allele were
present (i.e. with X~1 if Z~0 and with X~0 if Z~1), which
seems to us tenable (it is in fact not obvious to imagine a
subpopulation in which a causal gene would systematically
produce the contrary of what it is expected to, although this
cannot be verified from the data).
In the study analyzed by Amamoto et al. [22], 51.2% of
individuals own the protective allele (i.e. with Z~0). Among
persons with Z~0, 38.3% suffer from hypertension, whereas this
proportion is 48.2% in the group Z~1. According to the
population studied by Yamada et al. [23], the proportion of
individuals who drink alcohol in the group Z~1 is 90.8% while it
is 71.1% in the group Z~0. These proportions allow to calculate
the margins of a 26262 table summarizing the distribution of
(Z,X ,Y ). Unfortunately, we did not find comparable data
allowing to complete all cells of the table. For the sake of
illustration, we complete it by fixing the prevalence of hyperten-
sion at 39% in the group with X~1 and Z~0, and at 48.5% in
the group with X~1 and Z~1. Considering a total sample size of
n~2000 (to match our simulations), this leads to the fictitious data
summarized in Table 3.
Using the formulae given in the Methods section, the
proportions of always-takers and never-takers can be estimated
as bvA~(444z284)=(188z108z444z284)~0:711 (95%CI:
[0.683; 0.739]) and bvN~(50z40)=(50z40z456z430)~0:092
(95%CI: [0.074; 0.110]). This corresponds to an estimated
proportion of compliers of bvC~1{0:711{0:092~0:197
(95%CI: [0.164; 0.230]) (confidence intervals for vA, vN and
vC are here obtained by adding and subtracting 1.96 times the
standard error of the corresponding estimate, and using the fact
that bvA and bvN are independent). The proportions of hyperten-
sion among always-takers and never-takers are estimated bybp1A~284=(444z284)~0:390 and bp0N~40=(50z40)~0:444.
The proportion of hypertension among compliers in the group
Figure 3. Boxplots of the log odds-ratios estimated from 2000 simulations under various situations for each of the five methods
(from left to right: byAT , byITT , byIV , byADJ , byLC ). The sample size is n~2000 and the proportion of compliers is vC~0:5. The horizontal dashed line
represents the true log odds-ratio.
doi:10.1371/journal.pone.0035951.g003
Table 3. Allocation of the n~2000 individuals of our example
according to Z, X and Y.
Z~0 Z~1
X~0 X~1 X~0 X~1
Y~0 188 444 50 456
Y~1 108 284 40 430
doi:10.1371/journal.pone.0035951.t003
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Z~X~1 is then estimated as
bp1C~
(0:197z0:711)
430
456z430
{0:711:0:390
0:197
~0:829
and the proportion of hypertension among compliers in the group
Z~X~0 as
bp0C~
(0:197z0:092)
108
188z108
{0:092:0:444
0:197
~0:328:
We note in particular that bp1C is much higher than bp1A, which
is informative on the importance of confounding. Finally, the
odds-ratio measuring the causal effect of X on Y for compliers is
estimated as
byLC~ 0:829(1{0:328)0:328(1{0:829)~9:966
(when keeping all the decimals in the previous calculations). A
95% confidence interval for this odds-ratio calculated as in Lui
and Chang [13] yields [2.094; 47.423], which is a wide interval,
although it would still indicate a causal odds-ratio which is
significantly higher than 2.
Using the other approaches, we obtain byAT~1:276 (95%CI:
[1.017; 1.604]), byITT~1:498 (95%CI: [1.254; 1.790]),byIV~7:779 (95%CI: [2.978; 20.317]) and byADJ~7:793
(95%CI: [3.128; 21.887]). The confidence interval associated tobyIV is obtained using the qvf function in Stata, while the
confidence interval associated to byADJ is here computed from
10000 bootstrap replications. Consistent with our simulations,
these confidence intervals are somewhat narrower than the
confidence interval associated to byLC , but one cannot here infer
anything because of the unknown bias of these methods. We also
note that the upper bound of the narrow confidence interval
associated to the intention-to-treat estimate, whose bias is known
to be in the conservative direction, is still smaller than the lower
bound of the confidence interval associated to byLC .
Estimating Another Causal Odds-ratio
We have considered so far as target parameter the causal odds-
ratio y for the subpopulation of compliers. Besides being not
identifiable, this subpopulation might admittedly be difficult to
apprehend in the context of Mendelian randomization and it will
depend on the chosen genetic instrument. Other causal odds-ratios
have thus been considered as target parameters in the statistical
literature.
In particular, the logistic structural mean model (LSMM)
estimate described in Vansteelandt and Goetghebeur [14] has
been introduced to estimate a causal odds-ratio y for a
subpopulation of individuals being at risk, i.e. for whom one would
naturally observe X~1. There, the assumption (A1) is replaced by
another one:
(A2) the causal odds{ratio is the same for individuals with
X~1 and Z~0 or with X~1 and Z~1 :
Although the LSMM approach does not rely on (A1), we further
assume in what follows that there are no defiers to allow some
interesting comparison between the different estimates in that case.
According to the terminology employed here, individuals with
X~1 and Z~0 are representative of the always-takers, whereas
individuals with X~1 and Z~1 are representative of a
subpopulation composed of both the compliers and the always-
takers. Thus, using this approach, one is estimating y assuming
that
y~
p1A(1{p

0A)
p0A(1{p1A)
~
p1CA(1{p

0CA)
p0CA(1{p1CA)
,
where p0A denotes the proportion ofY~1 for always-takers that one
would get if one could intervene and set X~0, p0CA~(vCp0Cz
vAp

0A)=(vCzvA) and p1CA~(vCp1CzvAp1A)=(vCzvA) is as
in the Methods section. To calculate the LSMM estimate, one may
first calculate the estimate bp0A of p0A as the value satisfying this
assumption, that is
bp1A(1{bp0A)bp0A(1{bp1A)~
bp1CA(1{bp0CA)bp0CA(1{bp1CA) ,
where bp0CA~(bvCbp0CzbvAbp0A)=(bvCzbvA) and where bvA, bvC ,bp1CA, bp1A, bp1C and bp0C are as in the Methods section. Thus, bp0A is
the plausible solution of the quadratic equation a(bp0A)2zbbp0Az
c~0, with a~(1{w)(u{v), b~(u{v)(wbp0C{1)zwu and
c~{wubp0C , and with u~bp1A=(1{bp1A), v~bp1CA=(1{bp1CA)
and w~bvC=(bvCzbvA). The LSMM estimate byLSMM of y can
then be calculated either as
byLSMM~ bp1A(1{bp

0A)bp0A(1{bp1A)
or as
byLSMM~ bp1CA(1{bp

0CA)bp0CA(1{bp1CA) :
As far as we know, this is an original formulation of the LSMM
estimate in the context considered here. One can check that it
provides the same result as the equivalent explicit formulation forbyLSMM given in the Appendix of Vansteelandt et al. [11]. Applied
to our example from the previous subsection, one gets bp0A~0:116
and byLSMM~4:893. We note however that the assumption of
having the same causal odds-ratio in the subpopulation of always-
takers and in the subpopulation of both compliers and always-
takers is a very special one (and that its validity will also depend on
the chosen genetic instrument). Because of the non-collapsibility of
the odds-ratio (when pooling two subpopulations with the same
odds-ratio, one does not in general obtain the same odds-ratio, see
e.g. Greenland, Robins and Pearl [24]), it does not even imply that
the causal odds-ratio is the same for compliers and for always-
takers.
Actually, one could alternatively assume that
(A3) the causal odds{ratio is the same for compliers,
always{takers and never{takers
and hence that
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y~
p1C(1{p0C)
p0C(1{p1C)
~
p1A(1{p

0A)
p0A(1{p1A)
~
p1N (1{p0N )
p0N (1{p

1N )
,
where p1N denotes the proportion of Y~1 for never-takers that
one would get if one could intervene and set X~1. Making this
latter assumption, it would then become possible to estimate the
causal odds-ratio in the entire population, which we shall denote
by yz. Similarly to the LSMM estimate above, one would first
calculate estimates bpz0A and bpz1N of p0A and p1N as the values
satisfying
byLC~bp1C(1{bp0C)bp0C(1{bp1C)~
bp1A(1{bpz0A)bpz0A(1{bp1A)~
bpz1N (1{bp0N )bp0N (1{bpz1N ) ,
which are given by bpz0A~bp1A=(bp1AzbyLC(1{bp1A)) andbpz1N~byLCbp0N=(byLCbp0Nz1{bp0N ). The proportion pz1 of Y~1
in the entire population that one would get if one could intervene
and set X~1 is then estimated as
bpz1 ~bvCbp1CzbvAbp1AzbvNbpz1N ,
whereas the proportion pz0 of Y~1 in the whole population that
one would get if one could intervene and set X~0 is then
estimated as
bpz0 ~bvCbp0CzbvAbpz0AzbvNbp0N :
An estimate byz of yz is then simply obtained by
byz~bpz1 (1{bpz0 )bpz0 (1{bpz1 ) :
We did not find mention of such an estimate in the literature
and it might be interesting to study its statistical properties
(although it would rely on both assumptions (A1) and (A3) instead
of only either (A1) or (A2)). Applied to our example from the
previous subsection, one gets bpz0A~0:060, bpz1N~0:889,bpz1 ~0:523, bpz0 ~0:148 and byz~6:282. Interestingly, Balke
and Pearl [25] have derived bounds for pz1 and p
z
0 given the
(observed) distribution of (Z,X ,Y ), which can then be used to
derive bounds for yz. Note also that yz will be necessarily
smaller in magnitude than y because of the non-collapsibility of
the odds-ratio.
Discussion
In this paper, we have considered the problem of estimating a
causal odds-ratio for assessing the effect of a risk factor X on an
outcome Y using Mendelian randomization with a genetic
instrument Z in the special case where X, Yand Z are all binary.
We have confirmed via simulations that the usual adaptations of
the method of instrumental variable such as the qvf function of
Stata, or the adjusted version considered by Nagelkerke et al. [7]
and by Palmer et al. [8] are not valid estimates of the causal odds-
ratio in the subpopulation of compliers since a large bias may
occur, even with a large sample size. Palmer et al. [12] also
recognized that these estimates are not consistent for any causal
odds-ratio in this context. By contrast, the method recently
proposed by Lui and Chang [13], while being more variable than
the two methods above, does not suffer from this bias. While
Palmer et al. [12] noted that ‘‘estimation of complier causal effects
on the odds-ratio scale is more problematic’’, it is hence
encouraging to have a valid solution in the simple case considered
here (i.e. binary X, Y and Z). Further work is needed to estimate
whether and how this solution may be extended to more
complicated cases.
We have also recalled and illustrated that an instrumental
variable approach with a weak instrument, in our context with a
low proportion of compliers, might not be very useful because of
the huge variability of the estimate. With 10% of compliers, as
there are in many examples from the literature, the variability of
the estimate of Lui and Chang [13] (measured via the inter-
quartile range) can be up to 18 times higher than that of the
conventional as-treated or intention-to-treat estimates. With 30%
of compliers, the variability can still be up to 5 times higher. In our
example, we had about 20% of compliers and the confidence
interval obtained for the causal odds-ratio was still rather wide
even with a sample size of n~2000. Thus, the need to find
stronger instruments is probably as important as the need to
develop a methodology allowing to consistently estimate a causal
odds-ratio.
Another limitation of the considered approach is that the
subpopulation of compliers on which we restrict our attention is in
the context of Mendelian randomization ‘‘at the least unnatural
and a lot harder to grasp’’ than in the context of a clinical trial
with noncompliance, as noted by one anonymous reviewer. While
we agree with this statement, the question is whether there really is
a viable alternative. If one does not restrict one’s attention to the
compliers, one is considering always-takers and never-takers. As it
is by definition not possible to observe what would be the outcome
of an always-taker if he/she had X~0, or what would be the
outcome of a never-taker if he/she had X~1, one has to make
some speculative assumption in this regard. For example, the
assumption which is made when using the logistic structural mean
model estimate of Vansteelandt and Goetghebeur [14], for which
the target parameter is the causal odds-ratio in a subpopulation of
persons being at risk, is that the effect of the risk factor on the
outcome is the same in the subpopulation containing the always-
takers (and the defiers, if any) and in the subpopulation containing
the compliers and the always-takers. While such an assumption
might be defendable in a context where the effect is assessed via a
risk difference, it seems to us much more questionable in a context
where the effect is measured via an odds-ratio (because of the non-
collapsibility of the odds-ratio, and unless it is equal to one, it
would be quite special to have the same odds-ratio in two
subpopulations which partly, but not exactly coincide). This is why
we would personally prefer to assume instead that there are no
defiers and to use the estimate of Lui and Chang [13] (even if the
no defiers assumption is certainly also questionable; we are looking
forward to hearing more opinion of geneticists about situations
where this assumption might be verified and situations where it
might not).
In conclusion, we suggest that the approach of Lui and Chang
[13] might be a valuable solution for estimating a causal odds-ratio
between a binary risk factor and a binary outcome in the context
of a Mendelian randomization with a binary instrument, if we are
ready to assume no defiers and despite having to restrict our
attention to the compliers. About this latter restriction, we believe
that having a valid estimate of the causal effect in a subpopulation
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of human beings is of scientific interest. Most physiological
phenomena have indeed been discovered in a restricted set of
people and are usually widely applicable to larger sets of people.
That the set of compliers is not an identifiable one should not
invalidate this principle.
Acknowledgments
We thank two anonymous reviewers for their useful comments which led to
a significant improvement of the manuscript.
Author Contributions
Conceived and designed the experiments: PV MB VR. Performed the
experiments: PV. Analyzed the data: PV VR. Wrote the paper: PV MB
VR.
References
1. Goldberger AS (1972) Structural equations methods in the social sciences.
Econometrica 40: 979–1001.
2. Greenland S (2000) An introduction to instrumental variable for epidemiologists.
International Journal of Epidemiology 29: 722–729.
3. Hernan MA, Robins JM (2006) Instruments for causal inference: an
epidemiologist’s dream? Epi-demiology 17: 360–372.
4. Didelez V, Sheehan NA (2007) Mendelian randomization as an instrumental
variable approach to causal inference. Statistical Methods in Medical Research
16: 309–330.
5. Thomas DC, Conti DV (2004) Commentary: the concept of ‘Mendelian
Randomization’. International Journal of Epidemiology 33: 21–25.
6. Hardin JW, Schmiediche H, Carroll RJ (2003) Instrumental variables,
bootstrapping, and generalized linear models. The Stata Journal 3: 351–360.
7. Nagelkerke N, Fidler V, Bernsen R, Borgdorff M (2000) Estimating treatment
effects in randomized clinical trials in the presence of non-compliance. Statistics
in Medicine 19: 1849–1864.
8. Palmer TM, Thompson JR, Tobin MD, Sheehan NA, Burton PR (2008)
Adjusting for bias and unmeasured confounding in Mendelian randomization
studies with binary responses. International Journal of Epidemiology 37:
2057–2071.
9. Bochud M, Rousson V (2010) Usefulness of Mendelian randomization in
observational epidemiology. International Journal of Environmental Research
and Public Health 7: 711–728.
10. Didelez V, Meng S, Sheehan NA (2010) Assumptions of IV methods for
observational epidemiology. Statistical Science 25: 22–40.
11. Vansteelandt S, Bowden J, Babanezhad M, Goetghebeur E (2011) On
instrumental variables estimation of causal odds ratios. Statistical Science 26:
403–422.
12. Palmer TM, Sterne JAC, Harbord RM, Lawlor DA, Sheehan NA, et al. (2011)
Instrumental variable estimation of causal risk ratios and causal odds ratios in
Mendelian randomization analyses. American Journal of Epidemiology 173:
1392–1403.
13. Lui KJ, Chang KC (2010) Notes on odds ratio estimation for a randomized
clinical trial with noncompliance and missing outcomes. Journal of Applied
Statistics 37: 2057–2071.
14. Vansteelandt S, Goetghebeur E (2003) Causal inference with generalized
structural mean models. Journal of the Royal Statistical Society:
Series B (Statistical Methodology) 65: 817–835.
15. Angrist JD, Imbens GW, Rubin DB (1996) Identification of causal e_ects using
instrumental variable. Journal of the American Statisical Association 91:
444–455.
16. Sommer A, Zeger SL (1991) On estimating efficacy from clinical trials. Statistics
in Medicine 10: 45–52.
17. Baker SG (2011) Estimation and inference for the causal effect of receiving
treatment on a multinomial outcome: an alternative approach. Biometrics 67:
319–323.
18. R Development Core Team (2010) R: A Language and Environment for
Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria
(ISBN 3–900051–07–0). Available: http://www.R-project.org. Accessed 2012
Apr 19.
19. Stock JH, Wright JH, Yogo M (2002) A survey of weak instruments and weak
identi_cation in generalized method of moments. Journal of Business and
Economic Statistics 20: 518–529.
20. Burgess S, Thompson SG (2011) Avoiding bias from weak instruments in
Mendelian randomization studies. International Journal of Epidemiology 40:
755–764.
21. Takeshita T, Morimoto K (1999) Self-reported alcohol-associated symptoms and
drinking behavior in three ALDH2 genotypes among Japanese university
students. Alcoholism: Clinical and Experimental Research 23: 1065–1069.
22. Amamoto K, Okamura T, Tamaki S, Kita Y, Tsujita Y, et al. (2002)
Epidemiologic study of the association of low-Km mitochondrial acetaldehyde
dehydrogenase genotypes with blood pressure level and the prevalence of
hypertension in a general population. Hypertension Research 25: 857–864.
23. Yamada Y, Imai T, Ishizaki M, Honda R (2006) ALDH2 and CYP2E1
genotypes, urinary acetalde-hyde excretion and the health consequences in
moderate alcohol consumers. Journal of Human Genetics 51: 104–111.
24. Greenland S, Robins J, Pearl J (1999) Confounding and collapsibility in causal
inference. Statistical Science 14: 29–46.
25. Balke A, Pearl J (1997) Bounds on treatment effects from studies with imperfect
compliance. Journal of the American Statistical Association 92: 1171–1176.
Mendelian Randomization with All Binary Data
PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e35951
